Phase 2_Futibatinib_Cancers with FGFR aberrations_Taiho 120-202 A PHASE 2 STUDY OF FUTIBATINIB IN PATIENTS WITH SPECIFIC FGFR ABERRATIONS
- Abdelrahim, Maen (PI)
- Heyne, Kirk (Key Personnel)
- Singh, Monisha (Key Personnel)
Project: Clinical Trial
Project: Clinical Trial